FORT WORTH, Texas, July 7, 2021 /PRNewswire/ -- FDS Amplicare, Inc., a leading pharmacy software company, today announced it is awarding a $25,000 grant to Community Pharmacy Enhanced Services Network (CPESN) Minnesota to help independent pharmacies prepare for opportunities to expand their provider offerings for Medicaid patients.
The two-year program funded by the grant will help up to 50 community pharmacies receive implementation and training support to enable them to provide care under Medicaid CPT codes for Medication Therapy Management (MTM).
Minnesota is taking steps to ensure care for vulnerable populations, especially women and children, by offering expanded services in community pharmacies. The MTM program is focused on management of chronic diseases such as diabetes and hypertension. If patients with chronic conditions can maintain their medication programs, unexpected hospital admissions and other unplanned health episodes can be reduced.
According to the CDC, 6 out of every 10 adults have a chronic disease, and 4 in 10 have two or more. Medication therapy management — a service consisting of one-on-one medication reviews, action plans, and regular follow-up — has been proven to improve outcomes for patients with chronic health conditions. It is especially effective for patients with multiple chronic conditions, complex medication therapies, high prescription costs, and multiple prescribers.
"The pandemic made clear that community pharmacies are an integral part of our nation's healthcare ecosystem," said Adam McMullin, chief executive officer of FDS Amplicare. "This program will create opportunities for independent pharmacies in Minnesota to expand their healthcare services for residents of their communities. We are proud to be part of this effort, and we would like to see similar initiatives in other states."
Community pharmacies, many of which are located in rural and underserved areas where healthcare services may be difficult to access, have struggled in recent years to remain financially viable. The National Community Pharmacists Association (NCPA) estimates that 77% of community pharmacies serve population areas of 50,000 or fewer.
"It is vital that community pharmacies in rural, medically underserved areas expand the care services they offer," said Jason Ausili, chief clinical officer of FDA Amplicare. "The CPESN program enables pharmacists to be reimbursed for the expertise and care they are providing."
CPESN Minnesota is part of CPESN USA, a clinically integrated network of community pharmacies that coordinates patient care with broader care teams to provide medication optimization activities and enhanced services for high-risk patients.
"The MTM Service program highlights the strength of our Network and the value our members bring to their communities," said Lindsay Christensen, CPESN MN Network Facilitator. "Being located across the state of Minnesota, our Network members are uniquely positioned to help their patients navigate their medications and health care needs. We are excited to expand access to high-quality pharmacist care through this program."
About FDS Amplicare
FDS Amplicare strengthens the health of pharmacies and their patients. Through the delivery of innovative software products and services, we enable the evolution of the clinically focused New Era Pharmacy, empowering our clients to provide comprehensive pharmacy and clinical care services for their communities. Learn more at https://www.fdsrx.com.
About CPESN USA
CPESN USA a clinically integrated, nationwide organization of local networks whose participating pharmacies are accountable for the care they provide to patients. Being part of CPESN networks empowers community-based pharmacy practice by recognizing the value of enhanced services and encouraging other care providers to include community-based pharmacies in the patient care team. CPESN pharmacy provider networks are now in 45 states across America. Learn more at https://www.cpesn.com.
Kim Warth, Amendola Communications, [email protected]
SOURCE FDS Amplicare